Cochlear Limited D1190805. CP1000 Processor Size Comparison. 2019, Apr; Data on file. Mauger SJ, Jones M, Nel E, Del Dot J. Clinical outcomes with the Nucleus Kanso off-the-ear cochlear implant sound processor. Int J Audiol. Published online 09 Jan 2017 (DOI:10.1080/14992027.2016.1265156...
The Cochlear Sound Processor, Nucleus 7 (CP1000), includes Forward Focus, a spatial noise algorithm aimed to improve speech-in-noise performance, and Made for iPhone/iPod/iPad functionality. We conducted a prospective, single-center, open-label, within-participant, real-world evidence investigation...
Cochlear has received FDA approval for the Nucleus 7 (N7, or CP1000) BTE processor. This doesn’t mean the processor is available today – it’s up to the company to determine when it will be available. Preliminary features and differences between the N7 and N6 include: ...
which Google has developed in collaboration with GN Hearing and Cochlear. This new direct streaming technology from compatible* Android devices allows people to use their hearing devices like a headset to enjoy music, take calls
比前一代产品更小更轻的Nucleus 7人工耳蜗声音处理²提供舒适和安心的佩戴体验。 全球领先的植入式听力解决方案提供商澳大利亚科利耳公司(Cochlear)欣喜地宣布,其 Nucleus™ 7 声音处理器正式上市³,为改善全中国数百万重度至极重度感音神经性听力损失患者的生活迈出了具有里程碑意义的一步。
Outcomes for a clinically representative cohort of hearing-impaired adults using the Nucleus® CI532 cochlear implant. Eur. Arch. Oto-Rhino-Laryngol. 2020, 277, 1625–1635. [CrossRef] 35. Mosnier, I.; Bebear, J.-P.; Marx, M.; Fraysse, B.; Truy, E.; Lina-Granade, G.; Mondain,...